• Italiano
  • English
  • Svenska
  • Français
  • language selector

Gianluca Tognon

  • Homepage
  • About
    • My story
    • Publications
  • Services
    • Startup Consultant
    • Public speaking
  • Blog & Events
    • Diet & Health
    • Dairy Products
    • Children & School Food
    • Sports Nutrition
    • Diet & Beauty
    • Health Coaching
    • Eating for Pleasure
    • Food & Nutrition Law
    • Epidemiology & Data Science
    • Startups
  • Schedule a 30-min meeting
  • Contact
  • Events
  • Home
  • Diet & Health
  • Can selenium supplementation reduce thyroid auto-antibodies?
19 January 2021

Can selenium supplementation reduce thyroid auto-antibodies?

Can selenium supplementation reduce thyroid auto-antibodies?

by Gianluca Tognon / Thursday, 05 April 2018 / Published in Diet & Health
Selenium supplementation and Hashimoto thyroiditis

Recently, a friend of mine told me he had started taking selenium supplements after being diagnosed with Hashimoto thyroiditis. Intrigued by the idea that a selenium pill could curb such a common disease, I started to dig into the scientific literature regarding this topic. What I discovered is that, since 2002, several trials have investigated the effect of selenium supplements on thyroid autoantibodies in patients suffering from autoimmune thyroiditis, which is currently treated with levothyroxine (LT-4).

According to a recent systematic review and meta-analysis[1], selenium supplementation effectively reduces Thyroid Peroxidase Antibodies (TPOAb) levels at 3, 6, and 12 months as well as Thyroglobulin autoantibodies (TgAb) at 12 months in LT4-treated populations. Notably, in subjects not receiving thyroid hormone, there was a decrease in TPOAb and TgAb levels at very short-term (3 months) only, but not after 6 or 12 months of supplementation. In particular, in LT-4-treated subjects, a significant drop in TPOAb at three months was observed only in subjects receiving supplementation in the form of selenomethionine and not in those receiving sodium selenite. This might simply be due to the lower absorption rates of selenite compared to selenomethionine[2].

Although the idea that selenium supplementation could be a valid treatment for subjects suffering from autoimmune thyroiditis is an intriguing idea, there is no sufficient evidence to recommend this treatment as a valid alternative to LT-4. In addition, TPOAb reduction does not necessarily mean a better disease prognosis, since their role in the development of hypothyroidism is not completely clear.

This is not good news especially considering that women of reproductive age are often TPOAb-positive, and this is associated with an increased risk of infertility, pregnancy complications, and preterm delivery[3],[4]. Selenium supplementation does not seem to have any role in terms of either improved thyroid function or fertility rates in women planning pregnancy[5].

In conclusion, although supplementing selenium does not seem to solve the problems related to autoimmune thyroid diseases, it is still a good idea to have adequate intakes of this mineral. In another post I have described in more detail how to get enough selenium and which other nutrients are relevant for thyroid function.

——-

For those who want more science

Hashimoto’s thyroiditis (HT), also called chronic lymphocytic or autoimmune thyroiditis (AITD), is a chronic and autoimmune thyroid disease associated with thyroid hypofunction and thyroid autoantibodies production, the most common ones being: thyroid peroxidase antibodies (TPO-Ab) and thyroglobulin antibodies (Tg-Ab). Lymphocytic infiltration is also common[6],[7],[8],[9],[10]. HT prevalence is highest between 45-55 years, and it is between 4 to 10 times more frequent in women than in men. Curiously, smoking decreases the risk for HT, whereas alcohol, stress, pregnancy and use of some medications[11] can initiate the development of the disease in genetically-predisposed individuals[12],[13]. Although its exact mechanisms are not clear, HT is considered as a disorder of T cell-mediated immunity, caused by an interaction between susceptibility genes and environmental factors10. In most HT patients, lifelong levothyroxine substitution is required9,13,[14]. HT co-existance with both organ-specific[15] and non-specific diseases[16] should be evaluated together with other non-endocrine autoimmune diseases[17],[18].

 

[1] Wichmann J et al. Selenium supplementation significantly reduces thyroid autoantibody levels in patients

with chronic autoimmune thyroiditis: a systematic review and meta-analysis. Thyroid 2016;26:1681-93.

[2] Gärtner R, Duntas LH 2008 Effects of selenium supple- mentation on TPOAb and cytokines in acute autoimmune thyroiditis. Thyroid 18:669–670; author reply 673–664.

[3] Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A: Association be- tween thyroid autoantibodies and miscar- riage and preterm birth: meta-analysis of evi- dence. BMJ 2011;342:d2616.

[4] Krassas GE: Thyroid disease and female re- production. Fertil Steril 2000;74:1063–1070.

[5] Negro et al. A 2016 Italian survey about the clinical use of selenium in thyroid disease. Eur Thyroid J 2016;5:164–170.

[6] Caturegli P, DeRemigis A, Rose NR. Hashimoto thyroiditis: clinicaland diagnostic criteria. Autoimmun Rev 2014; 13: 391-7.

[7] Mazokopakis E, Papadakis JA, Papadomanolaki MG et al. Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto’s thyroiditis. Thyroid 2007; 17: 609-12.

[8] Mazokopakis EE, Tzortzinis AA, Dalieraki-Ott EI et al. Coexistence of Hashimoto’s thyroiditis with papillary thyroid carcinoma. A retros- pective study. Hormones (Athens) 2010; 9: 312-7.

[9] Mazokopakis EE, Chatzipavlidou V. Hashimoto’s thyroiditis and the role of selenium. Current concepts. Hell J Nucl Med 2007; 10: 6-8.

[10] Mazokopakis EE, Kotsiris DA. Hashimoto’s autoimmune thyroiditis and vitamin D de ciency. Current aspects. Hell J Nucl Med 2014; 17: 37-40.

[11] Such as iodine, interferon-gamma, immunomodulatory agents such as ipilimumab, pembrolizumab, nivolumab, and the humanised monoclonal antibody to CD52 alemtuzumab.

[12] E raimidis G, Wiersinga WM. Mechanisms in endocrinology: auto- immune thyroid disease: old and new players. Eur J Endocrinol 2014; 170: R241-52.

[13] Topliss DJ. Clinical update in aspects of the management of auto-immune thyroid diseases. Endocrinol Metab (Seoul) 2016; 31: 493-9.

[14] Pearce SH, Brabant G, Duntas LH et al. 2013 ETA guideline: manage- ment of subclinical hypothyroidism. Eur Thyroid J 2013; 2: 215-28.

[15] Such as pernicious anemia, vitiligo, celiac disease (CD), type 1 diabetes mellitus, autoimmune liver disease, primary biliary cirrhosis, myasthenia gravis, alopecia areata, sclerosis multiplex, Addison’s disease.

[16] Such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), Sjögren syndrome, systemic sclerosis, mixed connective tissue disease

[17] Dilas LT, Icin T, Paro JN, Bajkin I. Autoimmune thyroid disease and other non-endocrine autoimmune diseases. Med Pregl 2011; 64: 183-7.

[18] Boelaert K, Newby PR, Simmonds MJ et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 2010; 123: 183.e1-9.

Tagged under: Hashimoto, selenium supplements, thyroid, thyroid antibodies, thyroiditis
Gianluca Tognon

About Gianluca Tognon

Gianluca Tognon is an Italian nutrition coach, speaker, entrepreneur and former associate professor at the University of Gothenburg. He started his career as a biologist and spent 15 years working both in Italy and then in Sweden. He has been involved in several EU research projects and has extensively worked and published on the association between diet, longevity and cardiovascular risk across the lifespan, also studying potential interactions between diet and genes. His work about the Mediterranean diet in Sweden has been cited by many newspapers worldwide including the Washington Post and The Telegraph among others. As a speaker, he has been invited by Harvard University and the Italian multi-national food company Barilla.

What you can read next

Broccoli
5 Foods that battle cancer
Mediterranean diet
The science behind the Mediterranean diet
The dietary management of Chron's Disease
The dietary management of Crohn’s Disease

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Contacts

Gianluca Tognon
Askims Svedjeväg 28 Gothenburg, Sweden 436 42
Telephone: +46 727 335920
  • GET SOCIAL

© 2020 Tous droits réservés. Gianluca Tognon

TOP
Shares

We use cookies to offer you a better experience and analyze site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our policies

Privacy Preference Center

  • Privacy Policy
  • Cookie Policy
  • Terms of use
  • Complaint Form
  • Recity my account info
  • Delete my account
  • Export my data

Consent Management

By continuing to use this website, you consent to the use of cookies in accordance with our policies

Privacy Policy

Required
Privacy Policy

Cookie Policy

Required
Cookie Policy

Terms of use

Required
Terms of use

Complaint Form

Required
Register your complaint here. Please use this form for complaints only.

Recity my account info

Required
You have the right to rectify any data you deem to be incorrect or inaccurate. To submit your request to rectify any data we hold on you.

Delete my account

Required
If you don’t want us to keep your data; You can do this if you no longer use a service or your account

Export my data

Required
Access and export a copy of your account information data

Necessary

Determines whether the visitor has accepted the cookie consent box. This ensures that the cookie consent box will not be presented again upon re-entry.

Cookies Used

Required
_cmpQcif3pcsupported

Advertising

These are cookies that Google AdWords use to monitor performance of advertising and serve adverts to visitors based on the websites they’ve previously visited.

Cookies Used

ANID

Analytics

These cookies are used to collect information about how visitors use our Site. We use the information to compile reports and to help us improve the Site. The cookies collect information in an anonymous form, including the number of visitors to the Site, where visitors have come to the Site from and the pages they visited. If you do not allow these cookies we will not be able to include your visit in our statistics.

Cookies Used

_ga, _gat, _gid, UULE, fca_eoi_pagecount, 1P_JAR

Behavioural

Google set a number of cookies on any page that includes a Google Map. While we have no control over the cookies set by Google, they appear to include a mixture of pieces of information to measure the number and behaviour of Google Maps users.

Cookies Used

SID, SAPISID, APISID, SSID, HSID, NID